Curnutte J T, Scott P J, Mayo L A
Department of Basic and Clinical Research, Research Institute of Scripps Clinic, La Jolla, CA 92037.
Proc Natl Acad Sci U S A. 1989 Feb;86(3):825-9. doi: 10.1073/pnas.86.3.825.
The respiratory burst oxidase of neutrophils can be activated in a cell-free system in which plasma membranes, cytosol, Mg2+, and a membrane-perturbing detergent, such as arachidonate or sodium dodecyl sulfate, are all required. Using the technique of preparative isoelectric focusing, the cytosol factor required for oxidase activation was resolved into four components termed C1-C4 with respective pI values of approximately 3.1, 6.0, 7.0, and 9.5. Individually, these components were incapable of activating the oxidase and could only be detected in the presence of suboptimal amounts of normal cytosol that served to supply at least a limited amount of each of the required components. Attempts to activate the oxidase with a combination of the four components failed, suggesting that there might be a yet undetected fifth cytosolic component. Patients with autosomal recessive cytochrome b-positive chronic granulomatous disease (type II CGD) are severely deficient in cytosol factor activity. When added to cytosol samples from two patients with this form of CGD, component C4 restored the ability of each patient's cytosol to activate dormant oxidase. None of the other three cytosol factor components (C1-C3) was effective in this regard, a finding supported by the direct demonstration that these three components were present in normal amounts in this type of CGD. A different form of type II CGD was identified in a third patient on the basis of complementation studies in which the patient's cytosol was able to activate the oxidase in the cell-free system when mixed with cytosol from one of the first two patients. The defect in this third patient's cytosol could be partially corrected by component C2, but not component C4, obtained from normal cytosol. These findings indicate that the role of cytosol in the activation of the respiratory burst oxidase is more complex than previously appreciated in that at least four cytosolic components appear to be required. Defects in two of these components have now been identified and appear to be responsible for two biochemically distinct forms of CGD.
中性粒细胞的呼吸爆发氧化酶可在无细胞系统中被激活,该系统需要质膜、胞质溶胶、Mg2+以及一种膜扰动去污剂,如花生四烯酸盐或十二烷基硫酸钠。利用制备性等电聚焦技术,氧化酶激活所需的胞质溶胶因子被分解为四个组分,称为C1 - C4,其各自的pI值约为3.1、6.0、7.0和9.5。单独来看,这些组分无法激活氧化酶,只有在存在次优量的正常胞质溶胶时才能被检测到,正常胞质溶胶可提供至少有限量的每种所需组分。用这四种组分的组合激活氧化酶的尝试失败了,这表明可能存在尚未被检测到的第五种胞质组分。常染色体隐性细胞色素b阳性慢性肉芽肿病(II型CGD)患者的胞质溶胶因子活性严重缺乏。当将组分C4添加到两名患有这种形式CGD患者的胞质溶胶样品中时,它恢复了每名患者胞质溶胶激活休眠氧化酶的能力。其他三种胞质溶胶因子组分(C1 - C3)在这方面均无效,这一发现得到了直接证据的支持,即这三种组分在这种类型的CGD中含量正常。基于互补研究,在第三名患者中鉴定出了一种不同形式的II型CGD,在该研究中,当将该患者的胞质溶胶与前两名患者之一的胞质溶胶混合时,其胞质溶胶能够在无细胞系统中激活氧化酶。第三名患者胞质溶胶中的缺陷可通过从正常胞质溶胶中获得的组分C2部分纠正,但不能通过组分C4纠正。这些发现表明,胞质溶胶在呼吸爆发氧化酶激活中的作用比之前认识到的更为复杂,因为似乎至少需要四种胞质组分。现在已经鉴定出其中两种组分的缺陷,它们似乎是两种生化上不同形式的CGD的原因。